Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
HKD 14.0
(-0.99%)
HKD 14.0
(-0.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 21.41 Billion CNY | 52.9% |
| 2022 | 14 Billion CNY | 0.5% |
| 2021 | 13.93 Billion CNY | -0.83% |
| 2020 | 14.05 Billion CNY | 13.57% |
| 2019 | 12.37 Billion CNY | -15.59% |
| 2018 | 14.66 Billion CNY | 12.39% |
| 2017 | 13.04 Billion CNY | 149.64% |
| 2016 | 5.22 Billion CNY | -24.02% |
| 2015 | 6.87 Billion CNY | 67.25% |
| 2014 | 4.11 Billion CNY | 60.83% |
| 2013 | 2.55 Billion CNY | 1297.21% |
| 2012 | 182.97 Million CNY | -94.3% |
| 2011 | 3.2 Billion CNY | 157.6% |
| 2010 | 1.24 Billion CNY | -20.73% |
| 2009 | 1.57 Billion CNY | 131.91% |
| 2008 | 677.32 Million CNY | -44.91% |
| 2007 | 1.22 Billion CNY | 20.4% |
| 2006 | 1.02 Billion CNY | 0.64% |
| 2005 | 1.01 Billion CNY | 34.93% |
| 2004 | 751.96 Million CNY | 199.77% |
| 2003 | 250.84 Million CNY | -47.08% |
| 2002 | 473.99 Million CNY | 69.06% |
| 2001 | 280.37 Million CNY | 248.7% |
| 2000 | -188.54 Million CNY | -44.54% |
| 1999 | -130.44 Million CNY | 56.47% |
| 1998 | -299.7 Million CNY | -10553.36% |
| 1997 | -2.81 Million CNY | -112.27% |
| 1996 | 22.93 Million CNY | -18.64% |
| 1995 | 28.18 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 21.89 Billion CNY | 2.26% |
| 2024 Q3 | 14.04 Billion CNY | -21.49% |
| 2024 Q2 | 20.71 Billion CNY | -5.43% |
| 2023 Q1 | 15.3 Billion CNY | 9.28% |
| 2023 Q2 | 18.83 Billion CNY | 23.03% |
| 2023 Q3 | 20.33 Billion CNY | 7.96% |
| 2023 Q4 | 21.41 Billion CNY | 5.33% |
| 2023 FY | 21.41 Billion CNY | 52.9% |
| 2022 Q1 | 14.97 Billion CNY | 7.46% |
| 2022 FY | 14 Billion CNY | 0.5% |
| 2022 Q4 | 14 Billion CNY | -8.24% |
| 2022 Q3 | 15.26 Billion CNY | -13.9% |
| 2022 Q2 | 17.72 Billion CNY | 18.38% |
| 2021 Q3 | 13.89 Billion CNY | 3.21% |
| 2021 Q4 | 13.93 Billion CNY | 0.31% |
| 2021 FY | 13.93 Billion CNY | -0.83% |
| 2021 Q1 | 12.76 Billion CNY | -9.16% |
| 2021 Q2 | 13.46 Billion CNY | 5.45% |
| 2020 Q1 | 13.17 Billion CNY | 6.51% |
| 2020 FY | 14.05 Billion CNY | 13.57% |
| 2020 Q2 | 13.39 Billion CNY | 1.61% |
| 2020 Q3 | 15.87 Billion CNY | 18.55% |
| 2020 Q4 | 14.05 Billion CNY | -11.48% |
| 2019 FY | 12.37 Billion CNY | -15.59% |
| 2019 Q1 | 15.53 Billion CNY | 6.0% |
| 2019 Q2 | 15.51 Billion CNY | -0.15% |
| 2019 Q3 | 14.24 Billion CNY | -8.21% |
| 2019 Q4 | 12.37 Billion CNY | -13.12% |
| 2018 Q3 | 15.83 Billion CNY | 6.43% |
| 2018 FY | 14.66 Billion CNY | 12.39% |
| 2018 Q2 | 14.88 Billion CNY | 7.25% |
| 2018 Q4 | 14.66 Billion CNY | -7.44% |
| 2018 Q1 | 13.87 Billion CNY | 6.38% |
| 2017 Q4 | 13.04 Billion CNY | 112.48% |
| 2017 FY | 13.04 Billion CNY | 149.64% |
| 2017 Q3 | 6.13 Billion CNY | 3.43% |
| 2017 Q2 | 5.93 Billion CNY | -11.89% |
| 2017 Q1 | 6.73 Billion CNY | 28.92% |
| 2016 Q2 | 7.23 Billion CNY | -3.51% |
| 2016 Q4 | 5.22 Billion CNY | -19.53% |
| 2016 FY | 5.22 Billion CNY | -24.02% |
| 2016 Q3 | 6.49 Billion CNY | -10.29% |
| 2016 Q1 | 7.5 Billion CNY | 9.08% |
| 2015 Q4 | 6.87 Billion CNY | -6.13% |
| 2015 Q2 | 4.75 Billion CNY | 8.94% |
| 2015 FY | 6.87 Billion CNY | 67.25% |
| 2015 Q3 | 7.32 Billion CNY | 53.96% |
| 2015 Q1 | 4.36 Billion CNY | 6.23% |
| 2014 Q2 | 3.15 Billion CNY | -9.26% |
| 2014 Q1 | 3.47 Billion CNY | 35.8% |
| 2014 Q4 | 4.11 Billion CNY | -15.2% |
| 2014 FY | 4.11 Billion CNY | 60.83% |
| 2014 Q3 | 4.84 Billion CNY | 53.92% |
| 2013 FY | 2.55 Billion CNY | 1297.21% |
| 2013 Q4 | 2.55 Billion CNY | -21.85% |
| 2013 Q3 | 3.27 Billion CNY | 16.11% |
| 2013 Q2 | 2.81 Billion CNY | 254.63% |
| 2013 Q1 | 794.51 Million CNY | 334.23% |
| 2012 Q4 | 182.97 Million CNY | -95.27% |
| 2012 FY | 182.97 Million CNY | -94.3% |
| 2012 Q1 | 4.12 Billion CNY | 28.7% |
| 2012 Q2 | 4.4 Billion CNY | 6.59% |
| 2012 Q3 | 3.86 Billion CNY | -12.13% |
| 2011 Q4 | 3.2 Billion CNY | 5.93% |
| 2011 Q1 | 1.97 Billion CNY | 58.75% |
| 2011 Q2 | 2.1 Billion CNY | 6.33% |
| 2011 FY | 3.2 Billion CNY | 157.6% |
| 2011 Q3 | 3.02 Billion CNY | 44.06% |
| 2010 FY | 1.24 Billion CNY | -20.73% |
| 2010 Q1 | 1.6 Billion CNY | 2.28% |
| 2010 Q3 | 997.64 Million CNY | 35.67% |
| 2010 Q4 | 1.24 Billion CNY | 24.81% |
| 2010 Q2 | 735.33 Million CNY | -54.23% |
| 2009 Q1 | 1.02 Billion CNY | 51.63% |
| 2009 Q4 | 1.57 Billion CNY | -7.94% |
| 2009 Q3 | 1.7 Billion CNY | 13.97% |
| 2009 FY | 1.57 Billion CNY | 131.91% |
| 2009 Q2 | 1.49 Billion CNY | 45.76% |
| 2008 Q3 | 1.22 Billion CNY | 33.78% |
| 2008 Q4 | 677.32 Million CNY | -44.76% |
| 2008 Q1 | 1.09 Billion CNY | -11.29% |
| 2008 FY | 677.32 Million CNY | -44.91% |
| 2008 Q2 | 916.55 Million CNY | -15.96% |
| 2007 Q3 | 1.31 Billion CNY | 22.21% |
| 2007 Q2 | 1.07 Billion CNY | 7.55% |
| 2007 FY | 1.22 Billion CNY | 20.4% |
| 2007 Q1 | 1 Billion CNY | -2.03% |
| 2007 Q4 | 1.22 Billion CNY | -6.49% |
| 2006 Q2 | 803.5 Million CNY | -24.19% |
| 2006 Q4 | 1.02 Billion CNY | -16.58% |
| 2006 Q3 | 1.22 Billion CNY | 52.33% |
| 2006 Q1 | 1.05 Billion CNY | 4.46% |
| 2006 FY | 1.02 Billion CNY | 0.64% |
| 2005 Q3 | 1.09 Billion CNY | 9.33% |
| 2005 Q4 | 1.01 Billion CNY | -6.94% |
| 2005 Q1 | 896.27 Million CNY | 19.19% |
| 2005 Q2 | 997.22 Million CNY | 11.26% |
| 2005 FY | 1.01 Billion CNY | 34.93% |
| 2004 Q3 | 757.54 Million CNY | -0.91% |
| 2004 Q1 | 804.33 Million CNY | 220.65% |
| 2004 Q2 | 764.47 Million CNY | -4.96% |
| 2004 FY | 751.96 Million CNY | 199.77% |
| 2004 Q4 | 751.96 Million CNY | -0.74% |
| 2003 Q3 | 171.4 Million CNY | -73.6% |
| 2003 Q1 | 565.28 Million CNY | 19.26% |
| 2003 Q4 | 250.84 Million CNY | 46.35% |
| 2003 Q2 | 649.14 Million CNY | 14.83% |
| 2003 FY | 250.84 Million CNY | -47.08% |
| 2002 Q1 | 407.46 Million CNY | 45.33% |
| 2002 FY | 473.99 Million CNY | 69.06% |
| 2002 Q3 | 636.36 Million CNY | -12.48% |
| 2002 Q2 | 727.1 Million CNY | 78.45% |
| 2002 Q4 | 473.99 Million CNY | -25.52% |
| 2001 Q4 | 280.37 Million CNY | 0.0% |
| 2001 FY | 280.37 Million CNY | 248.7% |
| 2001 Q2 | 53.22 Million CNY | 0.0% |
| 2000 FY | -188.54 Million CNY | -44.54% |
| 2000 Q2 | 68.63 Million CNY | 0.0% |
| 2000 Q4 | -188.54 Million CNY | 0.0% |
| 1999 Q2 | -117.82 Million CNY | 0.0% |
| 1999 Q4 | -130.44 Million CNY | 0.0% |
| 1999 FY | -130.44 Million CNY | 56.47% |
| 1998 FY | -299.7 Million CNY | -10553.36% |
| 1998 Q4 | -299.7 Million CNY | 0.0% |
| 1998 Q2 | -414.06 Thousand CNY | 0.0% |
| 1997 FY | -2.81 Million CNY | -112.27% |
| 1996 FY | 22.93 Million CNY | -18.64% |
| 1995 FY | 28.18 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | 8378.208% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | -954.009% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | -360195.641% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | -7002.294% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | 112590.665% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | -69099.861% |
| Essex Bio-Technology Limited | -219.22 Million HKD | 9868.767% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | -8260.259% |
| PuraPharm Corporation Limited | 377.54 Million HKD | -5572.369% |
| SSY Group Limited | 1.71 Billion HKD | -1149.821% |
| JBM (Healthcare) Limited | -7.39 Million HKD | 289544.153% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | -6246.564% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 57.991% |